Phase IIa tolerability study of Voclosporin versus the standard of care for the treatment of Dry eye syndrome (DES)

Trial Profile

Phase IIa tolerability study of Voclosporin versus the standard of care for the treatment of Dry eye syndrome (DES)

Planning
Phase of Trial: Phase II

Latest Information Update: 27 Oct 2017

At a glance

  • Drugs Voclosporin (Primary)
  • Indications Dry eyes
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Oct 2017 New trial record
    • 20 Oct 2017 According to an Aurinia Pharmaceuticals media release, this trial is expected to begin by the second quarter of 2018 with data available in the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top